Drug Database
MO

moxisylyte hydrochloride (Erecnos / Icavex)

✓ Approved

Medea Research · Small Molecule · Small Molecule

What is moxisylyte hydrochloride?

moxisylyte hydrochloride is a small molecule developed by Medea Research. It is approved for therapeutic indications via injectable (others).

Drug Profile

Brand NamesErecnos, Icavex
CompanyMedea Research
Drug ClassSmall Molecule
RouteInjectable (Others)
StatusApproved

Therapeutic Indications

moxisylyte hydrochloride is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Reproductive system and breast disordersErectile dysfunction✓ Approved

Related Research Articles

PubMedDalton transactions (Cambridge, England : 2003)2026-11-12

Hydroxylamine hydrochloride as a multifunctional electrolyte additive for dendrite-free Zn deposition in aqueous Zn-ion batteries.

Liu Wei W, Jiang Ronghan R, Liu Tiancun T, Yin Xiaojie X et al.

Aqueous zinc-ion batteries (AZIBs) are attractive for large-scale energy storage because of their intrinsic safety and low cost. However, the practical utilization of AZIBs is limited by dendrite growth, hydrogen evolution, and interfacial corrosion. Here, hydroxylamine hydrochloride (HH) is introduced as a multifunctional electrolyte additive to regulate the Zn/electrolyte interface and Zn2+ transport. The electrolyte micro-environment can be optimized by HH additive with polar N- and O-based sites that interact with Zn ions and alter interfacial adsorption on the Zn surface. Electrochemical measurements have demonstrated the uniform Zn nucleation enhancement and suppressed hydrogen evolution and corrosion together with improved interfacial kinetics. Compared to pristine electrolyte, the Zn2+ transference number increases from 0.23 to 0.44, while the apparent interfacial desolvation activation energy decreases from 36.86 to 28.16 kJ mol-1. Consequently, symmetric Zn cells using HH-ZSO can stably cycle for more than 500 h at 5 mA cm-2 and 3 mAh cm-2, and asymmetric cells deliver an average coulombic efficiency of 99.67%. The corresponding full-cell tests also show improved cycling performance and slow capacity decay. These results establish HH as a simple molecular-scale electrolyte modifier for stabilizing aqueous Zn metal anodes.

PubMedZhonghua nan ke xue = National journal of andrology2026-11-12

[Clinical observation of Sanju Lihe decoction combined with low-intensity pulsed ultrasound in the treatment of type ⅢA prostatitis with qi stagnation and blood stasis].

Long Liuya L, Zhu Wenxiong W, Yuan Yifeng Y, Liu Tao T et al.

Objective To observe the clinical efficacy and safety of Sanju Lihe decoction combined with low-intensity pulsed ultrasound (LIPUS) in the treatment of type ⅢA prostatitis of qi stagnation and blood stasis pattern. Methods From September 2024 to December 2025, a total of 204 patients with type ⅢA prostatitis of qi stagnation and blood stasis pattern treated at the First Hospital of Hunan University of Chinese Medicine were enrolled and randomly divided equally into a control group and a treatment group. The control group received tamsulosin hydrochloride sustained-release capsules, moxifloxacin hydrochloride tablets, Sanju Lihe decoction, and health education. The treatment group was additionally treated with LIPUS on the basis of the control regimen. The treatment course lasted 4 weeks. During the treatment period, the dropped and excluded cases were recorded. Eventually, 195 cases were completed in the study, including 98 cases in the control group and 97 cases in the treatment group. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), 5-item International Index of Erectile Function (IIEF-5), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), traditional Chinese medicine (TCM) syndrome scores, uroflowmetry parameters (Qmax, Qave), grading of leukocytes and lecithin bodies in expressed prostatic secretions, clinical efficacy, and follow-up outcomes were compared between the two groups before and after treatment. Results After treatment, NIH-CPSI scores, TCM syndrome scores, and SAS/SDS scores were improved in both groups compared with baseline (P<0.05). The improvements in NIH-CPSI, IIEF-5, SAS, Qmax, Qave, and leukocyte grading in prostatic secretions were significantly better in the treatment group than those in the control group (P<0.05). No significant differences were observed between the two groups in SDS scores, TCM syndrome scores, or lecithin body grading in prostatic secretions after treatment (P>0.05). The total effective rate was 77.55% in the control group and 92.78% in the treatment group, with a significantly higher rate in the treatment group (P<0.05). At the 4-week follow-up after treatment, NIH-CPSI scores remained lower in the treatment group than in the control group (P<0.05). No serious adverse events occurred in either group during treatment. Conclusion On the basis of conventional medication and health education, Sanju Lihe decoction combined with LIPUS further relieves pain and voiding symptoms, improves sexual function, anxiety status, and uroflowmetry, and alleviates local prostatic inflammation in patients with type ⅢA prostatitis of qi stagnation and blood stasis pattern. The regimen is safe and worthy of clinical application.

PubMedJournal of neuroendovascular therapy2026-11-12

The Catheter-Based Mechanical Dilation Using a Spindle-Shaped Delivery Assist Catheter for Difficult-to-Access Cerebral Vasospasm Following Subarachnoid Hemorrhage.

Okada Takeshi T, Toma Naoki N, Wada Nami N, Kanamaru Hideki H et al.

Cerebral vasospasm (CVS) following subarachnoid hemorrhage (SAH) is sometimes difficult to treat with conventional balloon angioplasty due to limited device accessibility. We report catheter-based mechanical dilation using a spindle-shaped delivery assist catheter for CVS that is difficult to access with conventional balloon catheters. A 70-year-old man presented with severe SAH due to a ruptured anterior communicating artery aneurysm and underwent coil embolization along with ventricular drainage. On day 7, CVS of the left M1 segment of the middle cerebral artery (MCA) was treated with balloon angioplasty. On day 9, severe CVS of the left A1 segment of the anterior cerebral artery and the left M2 segment of the MCA was identified. A spindle-shaped delivery assist catheter was advanced to the distal left A1 segment, and mechanical dilation was performed by passing its bulb segment through the stenotic lesion. Subsequent angiography demonstrated vessel dilation. For the CVS in the left M2 segment, balloon angioplasty and selective intra-arterial fasudil hydrochloride infusion were performed. On day 14, newly developed vasospasm in the distal left M2 segment, beyond the segment previously treated with balloon angioplasty, was successfully dilated using the same technique. No procedure-related complications were observed, and no cerebral infarction developed in the treated vascular territories. Catheter-based mechanical dilation using a spindle-shaped delivery assist catheter may be considered as a feasible option for treating CVS when conventional balloon angioplasty is technically difficult. Further experience is required to determine its safety, efficacy, and durability.

PubMedZhonghua nan ke xue = National journal of andrology2026-11-11

[Effect of esketamine on anesthesia and postoperative analgesia in patients with prostate resection: Based on oxidative stress response].

Liu Dapeng D, Feng Lingling L, Yao Qun Q, Li Jianwei J et al.

Objective To investigate the effects of esketamine on postoperative analgesia, cognitive function, oxidative stress and safety in patients with electroprostatectomy. Methods One hundred and twenty patients who underwent electroprostatectomy in Zaozhuang Municipal Hospital from October 2021 to May 2022 were selected and divided into experimental group and control group according to the different treatment, with 60 cases in each group. The patients in control group were treated with routine sufentanil during the operation. And esketamine hydrochloride was used in the experimental group at the dosage of 0.2 mg/kg 10 minutes before the end of the operation. VAS score and MMSE score were recorded at 0.5, 2, 4 and 12 h after surgery. The levels of oxidative stress indexes including NE and GSH-Px were compared between the two groups, and the postoperative urinary tract irritation and adverse reactions were analyzed. Results There was significant difference in VAS score between the two groups at 0.5 h and 2 h after surgery (P<0.05), but no significant difference at 4 h and 12 h (P>0.05). There was significant difference in MMSE score at 0.5 h after operation (P<0.05). The scores of urethral irritation in the experimental group were significantly lower than those in the control group at 0.5 h and 2 h after operation (P<0.05), and the inhibition effect on urethral irritation was significant. After anesthesia, the levels of NE and GSH-Px in experimental group showed a more dramatic improvement compared to control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion Esketamine has good postoperative analgesic effect in elderly patients undergoing transurethral resection of prostate with a temporary effect on early postoperative cognitive function, which alleviates symptoms of urinary duct irritation and oxidative stress caused by surgery.

PubMedZhonghua nan ke xue = National journal of andrology2026-11-11

[Clinical efficacy and mechanism of Liniao Tonglin decoction in treating UU-infected oligoasthenospermia with dampness-heat pouring down syndrome].

Zhu Fanyu F, Li Ninghua N, Yang Wentao W

Objective To explore the clinical effect and mechanism of Liniao Tonglin decoction on oligoasthenospermia caused by Ureaplasma urealyticum (UU) infection with dampness-heat pouring down syndrome. Methods Eighty-eight patients were randomly divided into control group and observation group, with 44 cases in each group. The patients in control group were treated with doxycycline hydrochloride enteric-coated capsules and doxycycline tablets. While the patients in observation group were treated with Liniao Tonglin decoction on the basis of the treatment given to the control group. Both groups were treated for 14 days. Sperm concentration, total sperm count, progressive motility sperm rate(PR%), sperm motility rate([PR+NP]%), seminal plasmic elastase, interleukin-6(IL-6), interleukin-17(IL-17) levels TCM syndrome score and negative conversion rate of UU were compared between the two groups before and after the treatment. Results The overall efficacy rate of the observation group was significantly higher than that in the control group (86.05% vs 66.67% , χ2=4.435, P<0.05). UU negative conversion rate was also superior in the observation group (95.35% vs 88.10%,P>0.05). The increases in sperm concentration, total count, PR%, and (PR+NP)% (P<0.05) exhibited in both of two groups after the treatment, with significantly greater improvements in the observation group (P<0.05). The levels of seminal elastase, IL-6, IL-17 and TCM syndrome scores declined in both groups (P<0.05), with greater improvements in the observation group as well (P<0.05). Conclusion Liniao Tonglin decoction combined with antibiotics improves the count and motility of sperm and TCM syndrome score of oligoasthenospermia induced by UU infection with dampness-heat pouring down syndrome, increases the negative rate of UU, inhibits the expression of inflammatory factors, and changes the patency of reproductive tract and the living environment of sperm.

PubMedZhonghua zhong liu za zhi [Chinese journal of oncology]2026-11-11

[Mitoxantrone hydrochloride liposomes combined with R-GDP regimen in the treatment of relapsed/refractory diffuse large B-cell lymphoma: a single-arm, multicenter, exploratory clinical study].

Ma L L, Zhao J J, Wang J R JR, Zheng M J MJ et al.

Objective: To evaluate the efficacy and safety of the mitoxantrone liposome combined with R-GDP regimen (R-GDP-Mito regimen) in the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Methods: From May 2023 to September 2025, a total of 33 patients with relapsed/refractory DLBCL(R/R DLBCL) were enrolled from multiple centers, including Shanxi Provincial Cancer Hospital, Jincheng People's Hospital of Shanxi Province, Heping Hospital Affiliated to Changzhi Medical College, and Datong Second People's Hospital of Shanxi Province. All patients received 2 to 6 cycles of the R-GDP-Mito regimen. The short-term and long-term efficacy as well as adverse events were analyzed. Results: Among the 33 patients, 16 achieved complete remission (CR), 11 achieved partial remission (PR), 3 had stable disease (SD), and 3 experienced disease progression (PD). The objective response rate (ORR) was 81.8% (27/33), with a 95% CI of 61.4% to 92.3%. The median time to best response was 1.9 months. With a median follow-up of 4.8 months, disease progression was observed in 4 patients, and 5 patient deaths were recorded, attributed to disease progression and severe pulmonary infection, respectively. The median progression-free survival (PFS) was not reached, while the median overall survival (OS) was 16.1 months. The 1-year PFS and OS rates were 56.6% and 90.5%, respectively. All 33 patients experienced adverse events (AEs). Hematological AEs occurred in 60.6% (20/33) of patients, and non-hematological AEs occurred in 81.8% (27/33) of them. Conclusion: The R-GDP-Mitoregimen demonstrates high antitumor activity and well-controlled safety profile in R/R-DLBCL patients, offering a promising new therapeutic option, particularly for those unable to immediately access or tolerate novel targeted or immunotherapy regimens.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about moxisylyte hydrochloride